The synthetic opioid dipipanone is infrequently used in the UK in the management of malignant pain, principally because of the inflexibility of the Diconal combination preparation (dipipanone 10 mg with cyclizine 30 mg). We present three patients in which dipipanone elixir proved to be their own drug of choice in the management of opioid responsive cancer pain, and our experience with 15 other patients. Dipipanone elixir was formulated 10 mg/5 ml, in single strength chloroform water.
Ofner P., Walton RH, Green AF, White ACNew analgesics IV: Variations in the basic side chain amidone. Some pharmacological results. J Chem Soc1950;3:2158-66.
2.
Gillhespy RO , Cope E., Jones PODipipanone hydrochloride in the treatment of severe pain. A report of 200 cases. Br Med J1956; 2: 1094-96.
Gorman DJOpioid analgesics in the management of pain in patients with cancer: an update . Palliat Med1991; 5: 277-94.
5.
Zubrod CG, Scheiderman M., Frei M. et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide . J Chronic Dis1960 ; 11: 7-33.
6.
Galer BS, Coyle N., Pasternak GW, Porteoy RKIndividual variability in the response to different opioids: report of five cases. Pain1992; 49: 87-91.
